Nitrite regulation of shock

Cardiovascular Research

Volumn 89, Issue 3, 2011, Pages 553-559

  Cauwels, Anje ^a,b   Brouckaert, Peter ^a,b  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

LPS; Mitochondria; Nitrite; Shock; TNF

Indexed keywords

ANTIOXIDANT; GLYCERYL TRINITRATE; GUANYLATE CYCLASE; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; PEROXYNITRITE; S NITROSOTHIOL;

CYTOKINE PRODUCTION; DIETARY INTAKE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; HEART PROTECTION; HUMAN; MITOCHONDRIAL RESPIRATION; MULTIPLE ORGAN FAILURE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEPSIS; SEPTIC SHOCK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ANIMALS; HUMANS; MITOCHONDRIA; MULTIPLE ORGAN FAILURE; NITRIC OXIDE; NITRITES; SHOCK, SEPTIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79551483662     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvq317     Document Type: Review

References (84)

1. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003;348:1546-1554.
2. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29:1303-1310.
3. Erickson SE, Martin GS. Effect of sepsis therapies on health-related quality of life. Crit Care 2008;12:109.
4. Dellinger P, Parrillo J. Mediator modulation therapy of severe sepsis and septic shock: does it work? Crit Care Med 2004;32:282-286.
5. Riedemann NC, Guo RF, Ward PA. Novel strategies for the treatment of sepsis. Nat Med 2003;9:517-524.
6. Sandrock CE, Albertson TE. Controversies in the treatment of sepsis. Semin Respir Crit Care Med 2010;31:66-78.
7. Johnston GR, Webster NR. Cytokines and the immunomodulatory function of the vagus nerve. Br J Anaesth 2009;102:453-462.
8. Tracey KJ. Understanding immunity requires more than immunology. Nat Immunol 2010;11:561-564.
9. Mongardon N, Dyson A, Singer M. Is MOF an outcome parameter or a transient, adaptive state in critical illness? Curr Opin Crit Care 2009;15:431-436.
10. Russell JA, Singer J, Bernard GR, Wheeler A, Fulkerson W, Hudson L et al. Changing pattern of organ dysfunction in early human sepsis is related to mortality. Crit Care Med 2000;28:3405-3411.
11. Gatt M, Reddy BS, MacFie J. Review article: bacterial translocation in the critically ill- evidence and methods of prevention. Aliment Pharmacol Ther 2007;25:741-757.
12. Ince C. The microcirculation is the motor of sepsis. Crit Care 2005;9(Suppl. 4): S13-S19.
13. Trzeciak S, Cinel I, Phillip Dellinger R, Shapiro NI, Arnold RC, Parrillo JE et al. Resuscitating the microcirculation in sepsis: the central role of nitric oxide, emerging concepts for novel therapies, and challenges for clinical trials. Acad Emerg Med 2008;15: 399-413.
14. Brealey D, Brand M, Hargreaves I, Heales S, Land J, Smolenski R et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 2002;360:219-223.
15. Svistunenko DA, Davies N, Brealey D, Singer M, Cooper CE. Mitochondrial dysfunction in patients with severe sepsis: an EPR interrogation of individual respiratory chain components. Biochim Biophys Acta 2006;1757:262-272.
16. Cauwels A. Nitric oxide in shock. Kidney Int 2007;72:557-565.
17. Feihl F, Waeber B, Liaudet L. Is nitric oxide overproduction the target of choice for the management of septic shock? Pharmacol Ther 2001;91:179-213.
18. Pedoto A, Tassiopoulos AK, Oler A, McGraw DJ, Hoffmann SP, Camporesi EM et al. Treatment of septic shock in rats with nitric oxide synthase inhibitors and inhaled nitric oxide. Crit Care Med 1998;26:2021-2028.
19. Wright CE, Rees DD, Moncada S. Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res 1992;26:48-57.
20. Vincent JL, Zhang H, Szabo C, Preiser JC. Effects of nitric oxide in septic shock. Am J Respir Crit Care Med 2000;161:1781-1785.
21. Lopez A, Lorente JA, Steingrub J, Bakker J, McLuckie A, Willatts S et al. Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med 2004;32:21-30.
22. Hickey MJ. Role of inducible nitric oxide synthase in the regulation of leucocyte recruitment. Clin Sci 2001;100:1-12.
23. Wink DA, Miranda KM, Espey MG, Pluta RM, Hewett SJ, Colton C et al. Mechanisms of the antioxidant effects of nitric oxide. Antioxid Redox Signal 2001;3:203-213.
24. Dangel O, Mergia E, Karlisch K, Groneberg D, Koesling D, Friebe A. NO-sensitive guanylyl cyclase is the only NO receptor mediating platelet inhibition. J Thromb Haemost 2010;8:1343-1352.
25. Groneberg D, Konig P, Wirth A, Offermanns S, Koesling D, Friebe A. Smooth muscle-specific deletion of nitric oxide-sensitive guanylyl cyclase is sufficient to induce hypertension in mice. Circulation 2010;121:401-409.
26. Buys ES, Cauwels A, Raher MJ, Passeri JJ, Hobai I, Cawley SM et al. sGC{alpha}1 {beta}1 attenuates cardiac dysfunction and mortality in murine inflammatory shock models. Am J Physiol Heart Circ Physiol 2009;297:H654-H663.
27. Spronk PE, Ince C, Gardien MJ, Mathura KR, Oudemans-van Straaten HM, Zandstra DF. Nitroglycerin in septic shock after intravascular volume resuscitation. Lancet 2002;360:1395-1396.
28. Assadi A, Desebbe O, Kaminski C, Rimmele T, Benatir F, Goudable J et al. Effects of sodium nitroprusside on splanchnic microcirculation in a resuscitated porcine model of septic shock. Br J Anaesth 2008;100:55-65.
29. Boughton-Smith NK, Hutcheson IR, Deakin AM, Whittle BJ, Moncada S. Protective effect of S-nitroso-N-acetyl-penicillamine in endotoxin-induced acute intestinal damage in the rat. Eur J Pharmacol 1990;191:485-488.
30. Goto M, Zeller WP, Lichtenberg RC, Hurley RM. Diltiazem treatment of endotoxic shock in suckling rats. J Lab Clin Med 1992;120:465-470.
31. Laszlo F, Whittle BJ, Moncada S. Attenuation by nitrosothiol NO donors of acute intestinal microvascular dysfunction in the rat. Br J Pharmacol 1995;115:498-502.
32. Liu DD, Hsu YH, Chen HI. Endotoxin-induced acute lung injury is enhanced in rats with spontaneous hypertension. Clin Exp Pharmacol Physiol 2007;34:61-69.
33. Lundberg JO, Weitzberg E, Gladwin MT. The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov 2008;7:156-167.
34. Raat NJ, Shiva S, Gladwin MT. Effects of nitrite on modulating ROS generation following ischemia and reperfusion. Adv Drug Deliv Rev 2009;61:339-350.
35. Cauwels A, Buys ES, Thoonen R, Geary L, Delanghe J, Shiva S et al. Nitrite protects against morbidity and mortality associated with TNF- or LPS-induced shock in a soluble guanylate cyclase-dependent manner. J Exp Med 2009;206:2915-2924.
36. Milkowski A, Garg HK, Coughlin JR, Bryan NS. Nutritional epidemiology in the context of nitric oxide biology: a risk-benefit evaluation for dietary nitrite and nitrate. Nitric Oxide 2010;22:110-119.
37. Allen BW, Stamler JS, Piantadosi CA. Hemoglobin, nitric oxide and molecular mechanisms of hypoxic vasodilation. Trends Mol Med 2009;15:452-460.
38. Costa AD, Pierre SV, Cohen MV, Downey JM, Garlid KD. cGMP signalling in pre- and post-conditioning: the role of mitochondria. Cardiovasc Res 2008;77:344-352.
39. Shiva S, Sack MN, Greer JJ, Duranski M, Ringwood LA, Burwell L et al. Nitrite augments tolerance to ischemia/reperfusion injury via the modulation of mitochondrial electron transfer. J Exp Med 2007;204:2089-2102.
40. Singer M. Cellular dysfunction in sepsis. Clin Chest Med 2008;29:655-660, viii-ix.
41. Boulos M, Astiz ME, Barua RS, Osman M. Impaired mitochondrial function induced by serum from septic shock patients is attenuated by inhibition of nitric oxide synthase and poly(ADP-ribose) synthase. Crit Care Med 2003;31:353-358.
42. Erusalimsky JD, Moncada S. Nitric oxide and mitochondrial signaling: from physiology to pathophysiology. Arterioscler Thromb Vasc Biol 2007;27:2524-2531.
43. Clementi E, Brown GC, Feelisch M, Moncada S. Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione. Proc Natl Acad Sci USA 1998;95:7631-7636.
44. Iheagwara KN, Thom SR, Deutschman CS, Levy RJ. Myocardial cytochrome oxidase activity is decreased following carbon monoxide exposure. Biochim Biophys Acta 2007; 1772:1112-1116.
45. Szabo C. Hydrogen sulphide and its therapeutic potential. Nat Rev 2007;6:917-935.
46. Huet O, Obata R, Aubron C, Spraul-Davit A, Charpentier J, Laplace C et al. Plasma-induced endothelial oxidative stress is related to the severity of septic shock. Crit Care Med 2007;35:821-826.
47. Zapelini PH, Rezin GT, Cardoso MR, Ritter C, Klamt F, Moreira JC et al. Antioxidant treatment reverses mitochondrial dysfunction in a sepsis animal model. Mitochondrion 2008;8:211-218.
48. Cauwels A, Janssen B, Waeytens A, Cuvelier C, Brouckaert P. Caspase inhibition causes hyperacute tumor necrosis factor-induced shock via oxidative stress and phos-pholipase A2. Nat Immunol 2003;4:387-393. (Pubitemid 36432323)
49. 2 extraction during endotoxemia. Role of nitric oxide synthesis. Am J Respir Crit Care Med 1995;151:107-115.
50. 2 extraction capabilities during endotoxic shock. J Appl Physiol 1997;83:1164-1173. (Pubitemid 27433084)
51. Solaini G, Baracca A, Lenaz G, Sgarbi G. Hypoxia and mitochondrial oxidative metabolism. Biochim Biophys Acta 2010;1797:1171-1177.
52. Latz E. The inflammasomes: mechanisms of activation and function. Curr Opin Immunol 2010;22:28-33.
53. Kim YM, Talanian RV, Billiar TR. Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms. J Biol Chem 1997; 272:31138-31148.
54. Nisoli E, Falcone S, Tonello C, Cozzi V, Palomba L, Fiorani M et al. Mitochondrial biogenesis by NO yields functionally active mitochondria in mammals. Proc Natl Acad Sci USA 2004;101:16507-16512.
55. Clementi E, Nisoli E. Nitric oxide and mitochondrial biogenesis: a key to long-term regulation of cellular metabolism. Comp Biochem Physiol 2005;142:102-110.
56. De Palma C, Falcone S, Pisoni S, Cipolat S, Panzeri C, Pambianco S et al. Nitric oxide inhibition of Drp1-mediated mitochondrial fission is critical for myogenic differentiation. Cell Death Diff 2010;17:1684-1696.
57. Ong SB, Subrayan S, Lim SY, Yellon DM, Davidson SM, Hausenloy DJ. Inhibiting mito-chondrial fission protects the heart against ischemia/reperfusion injury. Circulation 2010;121:2012-2022.
58. Alzawahra WF, Talukder MA, Liu X, Samouilov A, Zweier JL. Heme proteins mediate the conversion of nitrite to nitric oxide in the vascular wall. Am J Physiol Heart Circ Physiol 2008;295:H499-H508.
59. Pinder AG, Pittaway E, Morris K, James PE. Nitrite directly vasodilates hypoxic vascu-lature via nitric oxide-dependent and -independent pathways. Br J Pharmacol 2009; 157:1523-1530.
60. van Faassen EE, Bahrami S, Feelisch M, Hogg N, Kelm M, Kim-Shapiro DB et al. Nitrite as regulator of hypoxic signaling in mammalian physiology. Med Res Rev 2009;29:683-741.
61. Shiva S. Mitochondria as metabolizers and targets of nitrite. Nitric Oxide 2010;22: 64-74.
62. Nagasaka Y, Fernandez BO, Garcia-Saura MF, Petersen B, Ichinose F, Bloch KD et al. Brief periods of nitric oxide inhalation protect against myocardial ischemia-reperfusion injury. Anesthesiology 2008;109:675-682.
63. Weinberger B, Fakhrzadeh L, Heck DE, Laskin JD, Gardner CR, Laskin DL. Inhaled nitric oxide primes lung macrophages to produce reactive oxygen and nitrogen intermediates. Am J Respir Crit Care Med 1998;158:931-938.
64. Cauwels A, Rogge E, Janssen B, Brouckaert P. Reactive oxygen species and small conductance calcium-dependent potassium channels are key mediators of inflammation-induced hypotension and shock. J Mol Med 2010;88:921-930.
65. Lee MY, Griendling KK. Redox signaling, vascular function, and hypertension. Antioxid Redox Signal 2008;10:1045-1059.
66. Victor VM, Apostolova N, Herance R, Hernandez-Mijares A, Rocha M. Oxidative stress and mitochondrial dysfunction in atherosclerosis: mitochondria-targeted anti-oxidants as potential therapy. Curr Med Chem 2009;16:4654-4667.
67. Westberg G, Shultz PJ, Raij L. Exogenous nitric oxide prevents endotoxin-induced glomerular thrombosis in rats. Kidney Int 1994;46:711-716.
68. Pastor CM, Payen DM. Effect of modifying nitric oxide pathway on liver circulation in a rabbit endotoxin shock model. Shock 1994;2:196-202.
69. Pastor CM, Losser MR, Payen D. Nitric oxide donor prevents hepatic and systemic perfusion decrease induced by endotoxin in anesthetized rabbits. Hepatology 1995; 22:1547-1553.
70. Zingarelli B, Halushka PV, Caputi AP, Cook JA. Increased nitric oxide synthesis during the development of endotoxin tolerance. Shock 1995;3:102-108.
71. Zhang H, Rogiers P, Friedman G, Preiser JC, Spapen H, Buurman WA et al. Effects of nitric oxide donor SIN-1 on oxygen availability and regional blood flow during endo-toxic shock. Arch Surg 1996;131:767-774.
72. Kumins NH, Hunt J, Gamelli RL, Filkins JP. Molsidomine increases endotoxic survival and decreases cytokine production. Shock 1997;7:200-205.
73. Gundersen Y, Saetre T, Carlsen H, Scholz T, Lilleaasen P, Aasen AO. Modulators of nitric oxide in porcine endotoxemia: effects on hepatic oxygen delivery and consumption. Eur Surg Res 1997;29:237-245.
74. Gundersen Y, Corso CO, Leiderer R, Dorger M, Lilleaasen P, Aasen AO et al. The nitric oxide donor sodium nitroprusside protects against hepatic microcirculatory dysfunction in early endotoxaemia. Intensive Care Med 1998;24:1257-1263.
75. Cochran JB, Genovese F, Ogura S, Teti G, Cook JA. Effect of nitric oxide donors and nitric oxide synthase inhibitors in neonatal rat endotoxic shock. Biochem Pharmacol 1999;58:687-691.
76. Brown KM, Brems JJ, Moazzam FN, Hartman GG, Gamelli RL, Ding JW. The nitric oxide donor molsidomine improves survival and reduces hepatocyte apoptosis in cholestasis and endotoxemia. J Am Coll Surg 2003;197:261-269.
77. Siegemund M, Van Bommel J, Sinaasappel M, Schwarte LA, Studer W, Girard T et al. The NO donor SIN-1 improves intestinal-arterial P(CO(2)) gap in experimental endotoxemia: an animal study. Acta Anaesthesiol Scand 2007;51:693-700.
78. Tamandl D, Jorgensen P, Gundersen Y, Fuegger R, Sautner T, Aasen AO et al. Nitric oxide administration restores the hepatic artery buffer response during porcine endo-toxemia. J Invest Surg 2008;21:183-194.
79. Johannes T, Mik EG, Klingel K, Goedhart PT, Zanke C, Nohe B et al. Effects of 1400W and/or nitroglycerin on renal oxygenation and kidney function during endotoxaemia in anaesthetised rats. Clin Exp Pharmacol Physiol 2009;36:870-879.
80. Bloomfield GL, Holloway S, Ridings PC, Fisher BJ, Blocher CR, Sholley M et al. Pretreat-ment with inhaled nitric oxide inhibits neutrophil migration and oxidative activity resulting in attenuated sepsis-induced acute lung injury. Crit Care Med 1997;25:584-593.
81. Bloomfield GL, Sweeney LB, Fisher BJ, Blocher CR, Sholley MM, Sugerman HJ et al. Delayed administration of inhaled nitric oxide preserves alveolar-capillary membrane integrity in porcine Gram-negative sepsis. Arch Surg 1997;132:65-75.
82. Neviere R, Guery B, Mordon S, Zerimech F, Charre S, Wattel F et al. Inhaled NO reduces leukocyte-endothelial cell interactions and myocardial dysfunction in endo-toxemic rats. Am J Physiol Heart Circ Physiol 2000;278:H1783-1790.
83. Neviere R, Mordon S, Marechal X, Buys B, Guery B, Mathieu D et al. Inhaled nitric oxide modulates leukocyte kinetics in the mesenteric venules of endotoxemic rats. Crit Care Med 2000;28:1072-1076.
84. Jakubowski A, Maksimovich N, Olszanecki R, Gebska A, Gasser H, Podesser BK et al. S-Nitroso human serum albumin given after LPS challenge reduces acute lung injury and prolongs survival in a rat model of endotoxemia. Naunyn Schmiedebergs Arch Pharmacol 2009;379:281-290.